Treat to target approach for asthma

References

• Ebmeier SJ, Thayabaran D, Braithwaite I, Bénamara C, Weatherall M, Beasley R. Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993–2012). Lancet 2017;390:935–945. doi:10.1016/S0140-6736(17)31448-4.
   PubMed Web of Science ®Google Scholar
• Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001;107:937–944.
   PubMed Web of Science ®Google Scholar
• Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report. London: Royal College of Physicians; 2014. Available from: http://www.rcplondon.ac.uk/sites/default/files/why-asthma-still-kills-full-report.pdf.
   Google Scholar
• Nannini LJ. Overreliance link between asthmatic subjects and short-acting β2 agonists. Pulm Pharmacol Ther 2018;50:80–81. doi:10.1016/j.pupt.2018.03.003.
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, Jordana M, Watson RM, Cockcroft DW, O’Byrne PM. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am J Respir Crit Care Med 1997;156:1738–1745. doi:10.1164/ajrccm.156.6.96-08042.
   PubMed Web of Science ®Google Scholar
• Kerrebijn KF, van Essen-Zandvliet EEM, Neijens JJ. Effect of long-term treatment with inhaled corticosteroids and betaagonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987; 79:653–659. doi:10.1016/S0091-6749(87)80163-X.
   PubMed Web of Science ®Google Scholar
• Vathenen AS, Knox AJ, Higgins BG, Britton JR, Tattersfield AE. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988;i:554–557. doi:10.1016/S0140-6736(88)91352-9.
   Google Scholar
• Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled albuterol and airway responsiveness to allergen. Lancet 1993;342:833–837. doi:10.1016/0140-6736(93)92695-P.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, O'Byrne PM, Swystun VA, Bhagat R. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J Allergy Clin Immunol 1995;96:44–49.
   PubMed Web of Science ®Google Scholar
• Manolitsas DN, Wang J, Devalia JL, Trigg CJ, McAulay AE, Davies RJ. Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am J Respir Crit Care Med 1995;151:1925–1930. doi:10.1164/ajrccm.151.6.7767541.
   PubMed Web of Science ®Google Scholar
• Page CP, Spina D. Beta2-agonists and bronchial hyperresponsiveness. Clin Rev Allergy Immunol 2006;31:143–162. doi:10.1385/CRIAI:31:2:143.
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J 2017;50:1701103. doi:10.1183/13993003.01103-2017.
   PubMed Web of Science ®Google Scholar
• Nannini LJ, Neumayer NS. Treatment step 1 for asthma should not be left blank, and SABA-only might not be a treatment step 1 option for asthma. Respiration 2018;95:212–214. doi:10.1159/000484568.
   PubMed Web of Science ®Google Scholar
• Spallarossa D, Battistini E, Silvestri M, Sabatini F, Fregonese L, Brazzola G, Rossi GA. Steroid-naive adolescents with mild intermittent allergic asthma have airway hyperresponsiveness and elevated exhaled nitric oxide levels. J Asthma 2003;40:301–310. doi:10.1081/JAS-120018629.
   PubMed Web of Science ®Google Scholar
• Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander I, Bousquet J. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998;157:403–409. doi:10.1164/ajrccm.157.2.96-08040.
   PubMed Web of Science ®Google Scholar
• van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001;164:2107–2113. doi:10.1164/ajrccm.164.11.2006165.
   PubMed Web of Science ®Google Scholar
• Grainge CL, Lau LCK, Ward JA, Dulay V, Lahiff G, Wilson S, Holgate S, et al. Effect of Bronchoconstriction on Airway remodeling in asthma. N Engl J Med 2011;364:2006–2015. doi:10.1056/NEJMoa1014350.
   PubMed Web of Science ®Google Scholar
• Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, Blais L, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994;149:604–610. doi:10.1164/ajrccm.149.3.8118625.
   PubMed Web of Science ®Google Scholar
• Busse WW, Pedersen S, Pauwels RA, Tan WC, Chen YZ, Lamm CJ, O'Byrne PM.START Investigators Group. The inhaled steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 2008;121:1167–1174. doi:10.1016/j.jaci.2008.02.029.
   PubMed Web of Science ®Google Scholar
• Selroos O. Effect of disease duration on dose-response of inhaled budesonide in asthma. Respiratory Medicine 2008;102:1065–1072. doi:10.1016/j.rmed.2007.12.029.
   PubMed Web of Science ®Google Scholar
• Singh JA, Saag KG, Bridges SL, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 2016;68:1–26. doi:10.1002/art.39480.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Bitton A, Katz JN, Radner H, Brown E, Fraenkel L. Treat to target in rheumatoid arthritis: fact, fiction or hypothesis? Arthritis Rheumatol (Hoboken, NJ). 2014;66:775–782. doi:10.1002/art.38323.
   PubMed Web of Science ®Google Scholar
• Garber AJ. Treat-to-target trials: uses, interpretation and review of concepts. Diabetes Obes Metab 2014;16:193–205. doi:10.1111/dom.12129.
   PubMed Web of Science ®Google Scholar
• Curtis JR, Shan Y, Harrold L, Zhang J, Greenberg JD, Reed GW. Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes. Arthritis Care Res (Hoboken) 2013;65:1707–1712. doi:10.1002/acr.22048.
   PubMed Web of Science ®Google Scholar
• Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, Chinchilli VM, et al. Daily versus as‐needed corticosteroids for mild persistent asthma. N Engl J Med 2005;352:1519–1528.
   PubMed Web of Science ®Google Scholar
• Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E, Crimi N, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007;356:2040–2052. doi:10.1056/NEJMoa063861.
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, et al. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med 2018;378:1865–1876. doi:10.1056/NEJMoa1715274.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Reddel HK, O’Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, et al. As-needed budesonide–formoterol versus maintenance budesonide in mild asthma. N Engl J Med 2018;378:1877–1887. doi:10.1056/NEJMoa1715275.
   PubMed Web of Science ®Google Scholar
• GINA Executive Committee. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2017. Available from: www.ginasthma.org [last accessed: 1 Aug, 2018].
   Google Scholar
• Anonymous. Using beta2 stimulants in asthma. Drug Ther Bull 1997;35:1–4.
   PubMedGoogle Scholar